期刊文献+

雷帕霉素纳米粒局部处理兔离体静脉对防治其移植后狭窄的作用 被引量:1

Pretreatment of isolated vein with rapamycin nanoparticles inhibits vein graft stenosis in rabbits
原文传递
导出
摘要 目的 研究用纳米缓释技术处理的雷帕霉素(RPM-NP)对移植静脉狭窄的防治作用.方法 选取家兔40只,建立兔颈外静脉间位移植至颈总动脉的移植静脉模型,按处理方式不同,分为4组:药物纳米局部干预组(RPM-NP局部处理颈外静脉,n=10,A组)、药物纳米全身干预组(RPMNP周围静脉滴注,n=10,B组)、空白纳米局部干预组(空白纳米粒局部处理颈外静脉,n=10,C组)和未干预组(不做上述处理,n=10,D组).术后28 d,切取各组移植静脉和对侧正常静脉,病理学检测移植静脉内膜厚度、内径、内膜/中膜厚度比以及胶原容积指数.结果 移植静脉的组织病理学检测结果表明,A、B、C、D组移植静脉和对侧正常静脉的内膜/中膜厚度比分别为0.26±0.02、0.73±0.05、0.71 ±0.04、0.69±0.03、0.24±0.01,胶原容积指数比分别为0.24±0.03、0.56±0.06、0.53±0.07、0.49±0.08、0.21 ±0.01.B、C、D组的组织病理学(移植静脉内膜厚度、内径、内膜/中膜厚度比以及胶原容积指数)与对侧正常静脉组比较,均出现明显的病理学改变,差异均有统计学意义(均P<0.05);3组之间移植静脉的组织病理学结果比较,差异均无统计学意义(均P>0.05).而A组移植静脉的组织病理学结果与对侧正常静脉比较,差异无统计学意义(P>0.05);与其他3组比较,差异有统计学意义(P<0.05).结论 采用纳米缓释技术处理的雷帕霉素,对离体的移植静脉行管腔内局部处理,能抑制移植静脉内膜增生,防治移植静脉狭窄. Objective To explore the effects of pretreatment of carbopol-encapsulated rapamycinloaded nanoparticles(RPM-NP)on vein graft stenosis in a rabbit vein graft model.Methods A segment of common carotid artery was replaced with a segment of external jugular vein in 40 rabbits.They were separated into four treatment groups,i.e.Group A:vein grafts were pretreated with intraluminal RPM-NP perfusion; Group B:peripheral venous veins were injected with RPM-NP; Group C:vein grafts received an equivalent perfusion of empty vehicle; Group D:vein grafts received no treatment.At Day 28 postoperation,the grafts and normal veins were harvested for histological examinations to analyze the indicators of intimal thickness,internal diameter,intimal/media thickness ratio and collagen volume index.Results At Day 28 post-operation,the intimal/media thickness ratios were 0.26 ± 0.02,0.73 ± 0.05,0.71 ± 0.04,0.69 ±0.03 and 0.24 ±0.01 in Groups A,B,C and D and the normal vein; the collagen volume index 0.24±0.03,0.56±0.06,0.53 ±0.07,0.49 ±0.08 and 0.21 ±0.01 respectively.Compared with the normal veins,the pathological indicators of vein graft intimal thickness,internal diameter,intimal/media thickness ratio and collagen volume index had significant differences in Groups B,C and D(all P 〈0.05).But there were no significant differences among 3 groups(all P 〉0.05).Compared with the normal vein,the parameters of vein graft intimal thickness,internal diameter,intimal/media thickness ratio and collagen volume index had no significant difference in Group A(all P 〉0.05).But as compared with other groups,these indicators had statistical significant difference in Group A(all P 〈 0.05).Conclusion The local pretreatment of isolated vein with rapamycin nanoparticles may inhibit neointimal hyperplasia and prevent effectively vein graft stenosis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第46期3298-3301,共4页 National Medical Journal of China
基金 山东省卫生厅医药卫生发展科技项目(2007HZ057)
关键词 西罗莫司 纳米粒子 局部治疗 移植静脉 狭窄 Sirolimus Nanoparticles Local treatment Vein graft Stenosis
  • 相关文献

参考文献15

  • 1Schachner T,Zou Y,Oberhuber A,et al.Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts.Ann Thorac Surg,2004,77:1580-1585.
  • 2尤庆生,陈宏林,孟小勇.血管外雷帕霉素缓释涂层抑制移植静脉再狭窄[J].中华胸心血管外科杂志,2007,23(6):401-403. 被引量:1
  • 3Zou W,Cao G,Xi Y,et al.New approach for local delivery of Rapamycin by Bioadesive PLGA-carbopol nanoparticles.Drug Deliv,2009,16:15-23.
  • 4Oberhoff M,Herdeg C,Shamet K,et al.Delivery of low molecular weight heparin via porous balloon catheter for prevention of smooth muscle cell proliferation.Circulation,1993,4:1023-1027.
  • 5Gimple LW,Gertz SD,Haber HL,et al.Effect of chronic subcutaneous or intramural administration of heparin femoral artery restenosis following balloon angioplasty in hypercholesterolemic rabbits.A quantitative angiographic and histopathological study.Circulation,1992,86:1536-1546.
  • 6van der Giessen WJ,Lincoff AM,Schwartz RS,et al.Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.Circulation l996 94.1f690-1697.
  • 7朱海龙,杨景学,张卫达,崔勤,陈文生.低剂量β-射线预防自体移植静脉内膜增生和狭窄的实验研究[J].中华实验外科杂志,2001,18(3):214-215. 被引量:4
  • 8Roque M,Cordon-Cardo C,Fuster V,et al.Modulation of apoptosis,proliferation,and p27 expression in a porcine coronary angioplasty model.Atherosclenosis,2000,153:315-322.
  • 9张鲁锋,肖锋,李简,王进,石志辉,李春英.局部缓释雷帕霉素抑制静脉移植血管内膜增生[J].中华医学杂志,2006,86(24):1706-1709. 被引量:9
  • 10Marks AR.Rapamycin:Signaling in vascular smooth muscle.Transplant Proc,2003,35(3 Suppl):231-233.

二级参考文献38

  • 1陶登顺,王辉山,汪曾炜,朱洪玉,张铁铮,姜志明.内皮型一氧化氮合酶基因转染防治移植静脉再狭窄的实验研究[J].中华外科杂志,2005,43(10):657-658. 被引量:7
  • 2贺进田,陶贤梅,莫炜,宋后燕.葡激酶突变体(K35R)PLGA微球的制备和表征(英文)[J].药学学报,2006,41(1):12-18. 被引量:13
  • 3Nwasokwa ON.Coronary artery bypass graft disease.Ann Intern Med,1995,123:528-545.
  • 4Marx SO,Marks AR.The development of rapamycin and implication to stent restenosis.Circulation,2001,104:852-855.
  • 5Marks AR.Rapamycin:Signaling in vascular smooth muscle.Transplatation Proceedings,2003,35 (Suppl 3A):231-233.
  • 6Chesebro JM,Fuster V.Platelet inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty:the basis of their use,data from animal studys,clinical trial data,and current recommendations.Cardiology,1986,73:292-305.
  • 7Ruygrok PN,Muller,Serruys PW,Rapamycine DW,in cardiovascular medicine.Intern Med J,2003,33:103-109.
  • 8Roque M,Cordon-Cardo C,Fuster V,et al.Modulation of apoptonis,proliferation,and p27 expresion in a porcine coronary angioplasty model.Atherosclerosis,2000,153:315-322.
  • 9Hu Z,Zou Y,Dietrich H,Wick G,et al.Inhibition of neointima hyperplasia of a mouse vein graft by locally applied suramin.Circulation,1999,100:861-868.
  • 10Davies MG,Hagen PO.Pathobiology of intima hyperplasia.Br J Surg,1994,81:1254-1260.

共引文献21

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部